Key statistics
On Friday, Lineage Cell Therapeutics Inc (BT3:DUS) closed at 0.795, 15.22% above the 52 week low of 0.69 set on Aug 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.785 |
---|---|
High | 0.805 |
Low | 0.785 |
Bid | 0.815 |
Offer | 0.86 |
Previous close | 0.795 |
Average volume | 0.00 |
---|---|
Shares outstanding | 188.84m |
Free float | 188.00m |
P/E (TTM) | -- |
Market cap | 177.51m USD |
EPS (TTM) | -0.1342 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:31 BST.
More ▼
Press releases
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
- Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
- Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
More ▼